Manulife (Manufacturers Life Insurance)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.7M Sell
1,072,476
-59,802
-5% -$5.08M 0.07% 272
2026
Q1
$97.6M Buy
1,132,278
+30,412
+3% +$2.73M 0.08% 224
2025
Q4
$96.2M Sell
1,101,866
-186,262
-14% -$14.1M 0.08% 232
2025
Q3
$73.8M Sell
1,288,128
-180,468
-12% -$10.4M 0.06% 276
2025
Q2
$86.7M Buy
1,468,596
+370,493
+34% +$23.9M 0.08% 235
2025
Q1
$80.4M Buy
1,098,103
+21,370
+2% +$1.77M 0.08% 232
2024
Q4
$89.1M Buy
1,076,733
+10,989
+1% +$867K 0.08% 241
2024
Q3
$76.2M Sell
1,065,744
-21,440
-2% -$1.51M 0.07% 268
2024
Q2
$74.5M Sell
1,087,184
-66,888
-6% -$4M 0.07% 257
2024
Q1
$61.9M Buy
1,154,072
+51,562
+5% +$2.77M 0.06% 282
2023
Q4
$58.8M Buy
1,102,510
+67,308
+7% +$3.28M 0.04% 309
2023
Q3
$51.4M Buy
1,035,202
+566,760
+121% +$31.7M 0.03% 318
2023
Q2
$27.9M Buy
468,442
+155
+0% +$8.83K 0.02% 495
2023
Q1
$26.5M Buy
468,287
+73,163
+19% +$4.69M 0.02% 522
2022
Q4
$29.3M Sell
395,124
-757
-0.2% -$51.5K 0.02% 465
2022
Q3
$23.6M Sell
395,881
-3,669
-0.9% -$221K 0.02% 527
2022
Q2
$22.4M Buy
399,550
+82,578
+26% +$5.43M 0.02% 568
2022
Q1
$23.4M Sell
316,972
-22,390
-7% -$1.56M 0.02% 616
2021
Q4
$24.5M Sell
339,362
-81,100
-19% -$5.89M 0.02% 586
2021
Q3
$32.2M Buy
420,462
+5,187
+1% +$416K 0.03% 484
2021
Q2
$32.2M Sell
415,275
-1,739
-0.4% -$124K 0.03% 494
2021
Q1
$25.7M Sell
417,014
-10,129
-2% -$641K 0.02% 553
2020
Q4
$27.9M Sell
427,143
-6,939
-2% -$399K 0.03% 502
2020
Q3
$21.5M Sell
434,082
-2,684
-0.6% -$138K 0.02% 514
2020
Q2
$20.7M Sell
436,766
-1,017,411
-70% -$49.1M 0.02% 524
2020
Q1
$61.8M Buy
1,454,177
+4,958
+0.3% +$245K 0.07% 257
2019
Q4
$85.3M Buy
1,449,219
+49,911
+4% +$2.71M 0.09% 224
2019
Q3
$70.4M Buy
1,399,308
+59,120
+4% +$2.82M 0.08% 239
2019
Q2
$56.7M Sell
1,340,188
-1,021
-0.1% -$44.3K 0.07% 277
2019
Q1
$66.3M Sell
1,341,209
-4,578
-0.3% -$207K 0.07% 251
2018
Q4
$58.2M Buy
1,345,787
+9,071
+0.7% +$453K 0.07% 260
2018
Q3
$75.9M Buy
1,336,716
+44,951
+3% +$2.37M 0.08% 240
2018
Q2
$65.2M Buy
1,291,765
+1,124,534
+672% +$58.6M 0.07% 271
2018
Q1
$8.33M Sell
167,231
-5,871
-3% -$276K 0.01% 981
2017
Q4
$7.11M Sell
173,102
-651,415
-79% -$22.8M 0.01% 1056
2017
Q3
$24.5M Sell
824,517
-129,214
-14% -$3.95M 0.03% 506
2017
Q2
$31.6M Sell
953,731
-151,693
-14% -$4.76M 0.04% 427
2017
Q1
$32.7M Buy
1,105,424
+23,026
+2% +$628K 0.04% 404
2016
Q4
$26.9M Buy
1,082,398
+953,739
+741% +$21.7M 0.04% 417
2016
Q3
$2.9M Buy
128,659
+81,405
+172% +$1.91M ﹤0.01% 1288
2016
Q2
$1.13M Sell
47,254
-250,640
-84% -$6.01M ﹤0.01% 1552
2016
Q1
$6.97M Buy
297,894
+905
+0.3% +$22.1K 0.01% 870
2015
Q4
$8.26M Buy
296,989
+539
+0.2% +$13.5K 0.01% 765
2015
Q3
$6.13M Buy
296,450
+1,425
+0.5% +$36.1K 0.01% 910
2015
Q2
$7.57M Sell
295,025
-1,272
-0.4% -$32.2K 0.01% 839
2015
Q1
$7.48M Buy
296,297
+85,586
+41% +$2.09M 0.01% 841
2014
Q4
$5.01M Sell
210,711
-86,890
-29% -$1.92M 0.01% 985
2014
Q3
$5.85M Buy
297,601
+255,316
+604% +$5.25M 0.01% 908
2014
Q2
$1.01M Sell
42,285
-105
-0.2% -$2.53K ﹤0.01% 1577
2014
Q1
$1.13M Sell
42,390
-33
-0.1% -$784 ﹤0.01% 1555
2013
Q4
$856K Sell
42,423
-385
-0.9% -$7.15K ﹤0.01% 1695
2013
Q3
$748K Sell
42,808
-1,663
-4% -$28.8K ﹤0.01% 1739
2013
Q2
$749K Buy
+44,471
New +$686K ﹤0.01% 1629

Other funds holding GMED

Manulife (Manufacturers Life Insurance)'s GMED Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Globus Medical (GMED) stake by 5.3% in Q2 2026, selling an estimated $5.08M and leaving 1,072,476 shares worth $84.7M. The position accounts for 0.07% of the portfolio, ranked #272.

Manulife (Manufacturers Life Insurance) first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $97.6M in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 1,072,476 shares of Globus Medical worth $84.7M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 59,802 Globus Medical shares in Q2 2026, an estimated $5.08M.
  • Globus Medical made up 0.07% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #272 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Globus Medical position peaked at $97.6M in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.